Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis

Robert W. Shaw; Hamish M. Fraser

doi:10.1016/0022-4731(84)90491-6

Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis

Robert W. Shaw, Hamish M. Fraser

In: Journal of Steroid Biochemistry · 1984 · vol. 20(6) , pp. 1403 · doi:10.1016/0022-4731(84)90491-6 · W2002572344

article OA: green CC0 ⤵ 1 in-corpus citation

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex

⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

This study investigated the effects of intranasal luteinizing hormone-releasing hormone agonist treatment in women diagnosed with endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Impact of gestrinone on the course of asymptomatic endometriosis. 1987

Cited by (1)

Impact of gestrinone on the course of asymptomatic endometriosis. 1987

Source provenance

openalex: last seen: 2026-06-10T17:14:06.276822+00:00

License: CC0 · commercial use OK